サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1732783

デジタルバイオマーカーの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Digital Biomarkers Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 164 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
デジタルバイオマーカーの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年05月01日
発行: Value Market Research
ページ情報: 英文 164 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタルバイオマーカーの世界市場規模は、2024年の47億4,000万米ドルから2033年には303億2,000万米ドルに成長し、2026年から2033年の予測期間中に22.91％の堅調な年間平均成長率（CAGR）を示すと予測されます。

デジタルバイオマーカー市場は、技術の進歩によって健康モニタリングや疾病管理のための革新的なソリューションの開発が可能になり、急速に拡大しています。デジタル機器を通じて収集される客観的かつ定量化可能な生理的・行動的データであるデジタルバイオマーカーは、ヘルスケアプロバイダーが患者の健康状態や治療効果を評価する方法を変えつつあります。ウェアラブル、モバイルアプリケーション、遠隔モニタリングツールを活用することで、ヘルスケア専門家は患者の状態をリアルタイムで把握できるようになり、より個別化されたプロアクティブケアにつながります。

さらに、人工知能と機械学習をデジタルバイオマーカー分析に統合することで、これらのツールの精度と予測能力が向上しています。AIアルゴリズムは膨大な量のデータを分析し、従来の方法では明らかにならなかったパターンや相関関係を特定することができるため、健康問題の早期発見やより効果的な介入が可能になります。このようなデータ主導型ヘルスケアへのシフトは、患者が自分の健康管理に積極的な役割を果たすことを可能にし、より大きな関与と治療計画へのアドヒアランスを促進します。

さらに、予防ヘルスケアと慢性疾患管理が重視されるようになり、デジタルバイオマーカーの需要が高まっています。世界中のヘルスケア・システムがコスト削減と治療成績の向上を目指す中、健康指標を遠隔かつ継続的にモニタリングする能力の価値はますます高まっています。デジタルバイオマーカーは、タイムリーな介入を促進し、入院を減らし、患者のQOL全体を向上させます。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 デジタルバイオマーカー産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 デジタルバイオマーカーの世界市場分析：タイプ別

  • タイプ別概要
  • タイプ別過去および予測データ分析
  • ウェアラブル
  • モバイルベースアプリケーション
  • センサー
  • その他

第6章 デジタルバイオマーカーの世界市場分析：臨床診療別

  • 臨床診療別概要
  • 臨床診療別過去および予測データ分析
  • 診断用デジタルバイオマーカー
  • モニタリングデジタルバイオマーカー
  • 予測・予後デジタルバイオマーカー
  • その他

第7章 デジタルバイオマーカーの世界市場分析：治療分野別

  • 治療領域別概要
  • 治療領域別過去および予測データ分析
  • 心血管および代謝疾患（CVMD）
  • 呼吸器疾患
  • 精神疾患
  • 睡眠および運動疾患
  • 神経疾患
  • 筋骨格系疾患
  • その他

第8章 デジタルバイオマーカーの世界市場分析：最終用途別

  • 最終用途別概要
  • 最終用途別過去および予測データ分析
  • ヘルスケア企業
  • ヘルスケアプロバイダー
  • 支払者
  • その他

第9章 デジタルバイオマーカーの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 デジタルバイオマーカー企業の競合情勢

  • デジタルバイオマーカー市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Amgen Inc.
  • Biogen Inc.
  • ActiGraph LLC
  • AliveCor Inc.
  • Empatica Inc.
  • IXICO Plc
  • Neurotrack Technologies Inc.
  • Clario
  • Koneksa
  • Huma
  • Sonde Health Inc.
  • Aural Analytics
  • Adherium Limited
  • Imagene AI
  • Brainomix
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Wearable Market Sales By Geography (USD MN)
  • Mobile Based Applications Market Sales By Geography (USD MN)
  • Sensors Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales By Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales By Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales By Geography (USD MN)
  • Other's Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales By Geography (USD MN)
  • Respiratory Disorders Market Sales By Geography (USD MN)
  • Psychiatric Disorders Market Sales By Geography (USD MN)
  • Sleep & Movement Disease Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Musculoskeletal Disorders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Healthcare Companies Market Sales By Geography (USD MN)
  • Healthcare Providers Market Sales By Geography (USD MN)
  • Payers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Digital Biomarkers Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Digital Biomarkers Report
  • Market Research Process
  • Market Research Methodology
  • Global Digital Biomarkers Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Clinical Practice
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Wearable Market Sales By Geography (USD MN)
  • Mobile Based Applications Market Sales By Geography (USD MN)
  • Sensors Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales By Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales By Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales By Geography (USD MN)
  • Other's Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales By Geography (USD MN)
  • Respiratory Disorders Market Sales By Geography (USD MN)
  • Psychiatric Disorders Market Sales By Geography (USD MN)
  • Sleep & Movement Disease Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Musculoskeletal Disorders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Healthcare Companies Market Sales By Geography (USD MN)
  • Healthcare Providers Market Sales By Geography (USD MN)
  • Payers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112111961

Global Digital Biomarkers Market size is anticipated to grow from USD 4.74 Billion in 2024 to USD 30.32 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 22.91% during the forecast period of 2026 to 2033.

The Digital Biomarkers Market is rapidly expanding as advancements in technology enable the development of innovative solutions for health monitoring and disease management. Digital biomarkers, which are objective, quantifiable physiological and behavioral data collected through digital devices, are transforming how healthcare providers assess patient health and treatment efficacy. By leveraging wearables, mobile applications, and remote monitoring tools, healthcare professionals can gain real-time insights into patient conditions, leading to more personalized and proactive care.

Moreover, the integration of artificial intelligence and machine learning into digital biomarker analysis is enhancing the accuracy and predictive capabilities of these tools. AI algorithms can analyze vast amounts of data to identify patterns and correlations that may not be apparent through traditional methods, enabling earlier detection of health issues and more effective interventions. This shift towards data-driven healthcare is empowering patients to take an active role in managing their health, fostering greater engagement and adherence to treatment plans.

Additionally, the growing emphasis on preventive healthcare and chronic disease management is driving demand for digital biomarkers. As healthcare systems worldwide seek to reduce costs and improve outcomes, the ability to monitor health metrics remotely and continuously is becoming increasingly valuable. Digital biomarkers can facilitate timely interventions, reduce hospitalizations, and enhance overall patient quality of life.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

  • Wearable
  • Mobile Based Applications
  • Sensors
  • Others

By Clinical Practice

  • Diagnostic Digital Biomarkers
  • Monitoring Digital Biomarkers
  • Predictive And Prognostic Digital Biomarkers
  • Other's

By Therapeutic Area

  • Cardiovascular And Metabolic Disorders (CVMD)
  • Respiratory Disorders
  • Psychiatric Disorders
  • Sleep & Movement Disease
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Others

By End-use

  • Healthcare Companies
  • Healthcare Providers
  • Payers
  • Others
  • COMPANIES PROFILED
  • Amgen Inc.
  • Biogen Inc.
  • ActiGraph LLC
  • AliveCor Inc.
  • Empatica Inc.
  • IXICO plc
  • Neurotrack Technologies Inc.
  • Clario
  • Koneksa
  • Huma
  • Sonde Health Inc.
  • Aural Analytics
  • Adherium Limited
  • Imagene AI
  • Brainomix
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. DIGITAL BIOMARKERS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Poerter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Clinical Practice
    • 3.7.3 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Wearable Historic and Forecast Sales By Regions
  • 5.4. Mobile Based Applications Historic and Forecast Sales By Regions
  • 5.5. Sensors Historic and Forecast Sales By Regions
  • 5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY CLINICAL PRACTICE

  • 6.1. Overview By Clinical Practice
  • 6.2. Historical and Forecast Data Analysis By Clinical Practice
  • 6.3. Diagnostic Digital Biomarkers Historic and Forecast Sales By Regions
  • 6.4. Monitoring Digital Biomarkers Historic and Forecast Sales By Regions
  • 6.5. Predictive And Prognostic Digital Biomarkers Historic and Forecast Sales By Regions
  • 6.6. Other's Historic and Forecast Sales By Regions

7. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY THERAPEUTIC AREA

  • 7.1. Overview By Therapeutic Area
  • 7.2. Historical and Forecast Data Analysis By Therapeutic Area
  • 7.3. Cardiovascular And Metabolic Disorders (CVMD) Historic and Forecast Sales By Regions
  • 7.4. Respiratory Disorders Historic and Forecast Sales By Regions
  • 7.5. Psychiatric Disorders Historic and Forecast Sales By Regions
  • 7.6. Sleep & Movement Disease Historic and Forecast Sales By Regions
  • 7.7. Neurological Disorders Historic and Forecast Sales By Regions
  • 7.8. Musculoskeletal Disorders Historic and Forecast Sales By Regions
  • 7.9. Others Historic and Forecast Sales By Regions

8. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data Analysis By End-use
  • 8.3. Healthcare Companies Historic and Forecast Sales By Regions
  • 8.4. Healthcare Providers Historic and Forecast Sales By Regions
  • 8.5. Payers Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE DIGITAL BIOMARKERS COMPANIES

  • 10.1. Digital Biomarkers Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF DIGITAL BIOMARKERS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Amgen Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Biogen Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. ActiGraph LLC
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. AliveCor Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Empatica Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. IXICO Plc
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Neurotrack Technologies Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Clario
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Koneksa
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Huma
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Sonde Health Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Aural Analytics
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Adherium Limited
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Imagene AI
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Brainomix
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies